Adirondack Research & Management Inc. Buys 8,000 Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)

Share on StockTwits

Adirondack Research & Management Inc. lifted its stake in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 3.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 238,900 shares of the software maker’s stock after purchasing an additional 8,000 shares during the period. Allscripts Healthcare Solutions accounts for approximately 2.1% of Adirondack Research & Management Inc.’s holdings, making the stock its 17th largest holding. Adirondack Research & Management Inc. owned about 0.15% of Allscripts Healthcare Solutions worth $1,617,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Versant Capital Management Inc boosted its position in shares of Allscripts Healthcare Solutions by 11,786.5% in the 2nd quarter. Versant Capital Management Inc now owns 4,398 shares of the software maker’s stock worth $29,000 after purchasing an additional 4,361 shares during the last quarter. Advisor Group Holdings Inc. bought a new position in shares of Allscripts Healthcare Solutions in the 1st quarter worth $34,000. PNC Financial Services Group Inc. boosted its position in shares of Allscripts Healthcare Solutions by 147.7% in the 2nd quarter. PNC Financial Services Group Inc. now owns 10,055 shares of the software maker’s stock worth $68,000 after purchasing an additional 5,995 shares during the last quarter. Aigen Investment Management LP bought a new position in shares of Allscripts Healthcare Solutions in the 2nd quarter worth $68,000. Finally, Grantham Mayo Van Otterloo & Co. LLC bought a new position in shares of Allscripts Healthcare Solutions in the 1st quarter worth $74,000.

Shares of Allscripts Healthcare Solutions stock traded down $0.18 during trading on Friday, hitting $8.80. The company’s stock had a trading volume of 1,278,800 shares, compared to its average volume of 1,155,362. Allscripts Healthcare Solutions Inc has a 52 week low of $4.56 and a 52 week high of $11.82. The stock has a 50-day moving average price of $8.52 and a two-hundred day moving average price of $7.15. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of -26.67, a price-to-earnings-growth ratio of 2.17 and a beta of 1.08. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.78 and a quick ratio of 0.78.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, July 30th. The software maker reported $0.18 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.08 by $0.10. Allscripts Healthcare Solutions had a negative net margin of 3.06% and a positive return on equity of 5.55%. The firm had revenue of $406.20 million during the quarter, compared to the consensus estimate of $399.80 million. On average, equities analysts predict that Allscripts Healthcare Solutions Inc will post 0.45 EPS for the current fiscal year.

MDRX has been the topic of several research analyst reports. BidaskClub downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, August 26th. Cantor Fitzgerald raised their price objective on Allscripts Healthcare Solutions from $6.00 to $9.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. TheStreet raised Allscripts Healthcare Solutions from a “d” rating to a “c-” rating in a research note on Friday, July 31st. Goldman Sachs Group downgraded Allscripts Healthcare Solutions from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $6.50 to $5.50 in a research note on Tuesday, July 21st. Finally, Canaccord Genuity reaffirmed a “buy” rating on shares of Allscripts Healthcare Solutions in a research note on Friday, July 31st. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $9.03.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

See Also: 52- Week Highs

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply